000 a
999 _c11232
_d11232
003 OSt
005 20200213150715.0
008 200213b xxu||||| |||| 00| 0 eng d
040 _aAIKTC-KRRC
_cAIKTC-KRRC
100 _912223
_aRukminingsih, Fef
245 _aHEALTH- RELATED QUALITY OF L IFE IN EARLY BREAST CANCER PATIENTS WITH HORMON E RESPONSIVE
250 _aVol.10(12)
260 _aM P
_bInnovare Academic Sciences Pvt Ltd
_c2018
300 _a47-49p.
520 _aObjective : The management of early breast cancer (EBC) is performed with a series of treatments consisting of surgery and systemic therapy, along with long -term endocrine therapy for hormone responsive. The treatment generates a high illness effect that will affect the life quality of EBC patients. Th e objective of this study was to measure EBC patients ’ quality of life after undergo ing the treatment. Method s: A cross -sectional study was conducted by interviewing EBC patients using EQ -5D -5L instrument at private hospital s in Yogyakarta and Semarang , Indonesia . The EBC patients were women aged 18 -60 y who ha d undergone surgery in 2010 -2013 and receive d endocrine ther apy. Result s : Of the 71 patients identified , 45 patients were in disease -free survival (DFS) state , 8 patients were in locoregional recurrence (LR), and 18 patients were in metastasis (M) state . Mobil ity and self -care problems occurred in patients who had metastasis (4. 23%). The p roblem of usual activities occur ed in patients who had recurrence (22. 54%). Most of the patients (84.51%) had pain problem , and all patients had an anxiety problem. The mean utility score (SD) in DFS patient s was 0.841 (0.052) , in LR patients w as 0.758 (0.092) , and in patients who had metastasis was 0. 653 (0.104). The mean scores of EQ -5D VAS (SD) for EBC patients in DFS, LR and M health state were 86.56 (6.29), 81.88 (5.30), and 69.17 (5.75), respectively. Concl usio n : The health states of EBC significantly affect HRQOL of patients . Efforts should be made to improve the quality of life of EBC patie nts especially in terms of pain and anxiety reduction.
650 0 _94639
_aPHARMACEUTICS
700 _912224
_aAndayani, Tri Murti
773 0 _tInternational journal of pharmacy and pharmaceutical science
_dBhopal Innovare Academic Sciences Pvt Ltd
_x2656-0097
856 _uhttps://innovareacademics.in/journals/index.php/ijpps/article/view/29648/16285
_yClick here
942 _2ddc
_cAR